For the development of drugs or vaccines against COVID-19, research needs virus proteins of high purity. For most of the SARS-CoV-2 proteins, scientists at Goethe University Frankfurt and a total of 36 partner laboratories have now developed protocols that enable the production of several milligrams of each of these proteins with high purity, and allow […]
Due to the immunological pathogenesis of IgA nephropathy (IgAN), patients used to be given immunosuppressive therapy; however, this was shown to have no long-term benefit over optimal supportive therapy.
Uniqsis is making flow chemistry accessible to everyone, while at the same time catering for multi-step and automated reactions sequences, through the availability of an expanding suite of affordable ‘plug and play’ reactor modules. Compatible with all Uniqsis coil reactors and with an operating temperature range of ambient to +300°C, the HotCoil reactor heating module […]
Neurons, nerve cells in the brain, are central players in brain function. However, a key role for glia, long considered support cells, is emerging. A research group at the University of Basel has now discovered two new types of glial cells in the brain, by unleashing adult stem cells from their quiescent state. These new […]
Porvair Sciences has launched new kit for rapid extraction of total RNA from a wide range of biological samples.
The U.S. FDA has approved Aduhelm (aducanumab) developed by Biogen, Cambridge, Massachusetts, for the treatment of Alzheimer’s. Aduhelm was approved using the ‘accelerated approval pathway’.
Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, have launched a biocompatible CYTRIX Microfluidic Hydrogel Kit.
The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at the OBN 2020 Awards. The award recognises the company’s outstanding contribution to the fight against COVID-19.
BioChromato has developed an enzyme assay product – the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies.
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, has received a patent from the Japan Patent Office for their oncolytic virus (OV) backbone VVcopTK-RR- that encodes one or more immune checkpoint inhibitors (ICIs).
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
